Overview

Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"

Status:
Completed
Trial end date:
2013-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of long-term use of Voglibose (Basen) to prevent progression to type 2 diabetes mellitus in participants with impaired glucose tolerance in the routine clinical setting.
Details
Lead Sponsor:
Takeda
Treatments:
Inositol
Voglibose